Company news
Cipher Pharmaceuticals Inc. news in 2016
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2016, newest first.
Cipher Pharmaceuticals Reports Q3 2016 Financial Results
November 11, 2016
Cipher Pharmaceuticals Announces Management Change
November 11, 2016
Notice of Cipher Pharmaceuticals Inc. Q3 2016 Conference Call
October 27, 2016
Cipher Pharmaceuticals appoints Stephen Lemieux as Chief Financial Officer
September 1, 2016
Cipher Pharmaceuticals Reports Q2 2016 Results Highlighted by 32% Revenue Growth and $3.1 Million Cash from Operations
August 10, 2016
Cipher Pharmaceuticals Inc. Announces Changes to its Board of Directors
August 9, 2016
Cipher Pharmaceuticals Announces Preliminary Q2 2016 Results Highlighted by 30+% Revenue Growth and $3.0+million Cash from Operations
August 3, 2016
Notice of Cipher Pharmaceuticals Inc. Q2 2016 Conference Call
July 20, 2016
Cipher Pharmaceuticals announces Ozenoxacin accepted for review by Health Canada
July 12, 2016
Special Committee of Cipher Pharmaceuticals Responds to Early Warning Report Filed by 1207407 Ontario Limited
July 6, 2016
Cipher Pharmaceuticals Out-Licenses Rights to ASF-1096 for Anorectal Disorders
June 20, 2016
Cipher Pharmaceuticals to Present at Two Upcoming U.S. Investor Conferences
May 31, 2016
Cipher Pharmaceuticals Reports Q1 2016 Financial Results
May 5, 2016
Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University's Investigational Tattoo Removal Cream
May 2, 2016
Notice of Cipher Pharmaceuticals Q1 2016 Conference Call & Annual and Special Meeting
April 22, 2016
Cipher Pharmaceuticals Announces Retirement of CFO Norm Evans
April 22, 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors
April 7, 2016
Cipher Pharmaceuticals Announces Approvals of Astion Acquired Barrier Creams by Health Canada and the Medicines Evaluation Board
April 6, 2016
Cipher Pharmaceuticals announces Canadian launch of Beteflam(TM)
April 5, 2016
Cipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Business
March 4, 2016
Cipher Pharmaceuticals to Present at Two Upcoming Investor Conferences
March 3, 2016
Cipher Pharmaceuticals Reports 2015 Financial Results
February 24, 2016
Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall(TM)
February 22, 2016
Cipher Pharmaceuticals Inc. announces Sitavig(TM) accepted for review by Health Canada
February 16, 2016
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call
February 9, 2016